MarketsandMarkets In Vitro Diagnostics Crystal Ball Event
The in-vitro diagnostics market is expected to reach USD 96.07 billion by 2025 at a CAGR of 2.6% during the forecast period. The rising geriatric population and the subsequent growth in the prevalence of chronic and infectious diseases, growing awareness regarding diseases diagnosis in developing regions, increasing adoption of fully automated and POC instruments in developed regions, and growing R&D investments by industry players to launch new IVD products are the major factor supporting growth of the in-vitro diagnostics market.
The development of condition-specific markers and tests, growing significance of companion diagnostics, POC tests with multiplexing capabilities are the factors expected to provide significant growth opportunities in the coming years.
This Crystal Ball event focuses on learning more about the most promising opportunities in the composites market, as seen through the lens of eminent CXOs in this space.
Top 10 disruptions in In-Vitro Diagnostics Ecosystem
90 minutes of brainstorming among 4 great minds which will aim at bringing out a tangible action plan by discussing the question given below:
Head of In-Vitro Diagnostics, The Technology Partnership
Business Head - Molecular Diagnostics, Qiagen
Director, Global Access, Cepheid
Director – Speciality Diagnostics & Genetic Science Group, South Asia, Thermo Fisher Scientific.
Senior Manager (Healthcare), MarketsandMarkets
AVP, Strategic Account Business Development, MarketsandMarkets